Praxis Biologics
Executive Summary
Founder David Smith, MD, files formal demand requesting a special shareholders meeting on April 18. Smith, who owns 48% of Praxis and sits on the company's board, is seeking to remove the other five directors following their decision not to reinstate Smith as CEO, a position from which he stepped down at the end of 1987 ("The Pink Sheet" March 14, T&G-7).